#ACR14 Franingham Risk does not perform well in seropositive RA. http://t.co/p8jnlbKosx — RheumReports.com (@Rheumreports) November 18, 2014
#ACR14 Franingham Risk does not perform well in seropositive RA. http://t.co/p8jnlbKosx